世界の吸入麻酔薬市場インサイト及び予測(揮発性麻酔薬、亜酸化窒素、ハロタン、その他)

◆英語タイトル:Global Inhalational Anesthetic Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX10385)◆商品コード:QY22JLX10385
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:127
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,489,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、吸入麻酔薬のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に吸入麻酔薬の世界市場のxxx%を占める「揮発性麻酔薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
吸入麻酔薬の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの吸入麻酔薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

吸入麻酔薬のグローバル主要企業には、Linde Healthcare、Air Products、Taiyo Nippon Sanso、Messer Group、SOL Group、Pfizer、Norco、Piramal Group、Halocarbon、Dideu Group、Innopharmchem、Aesica(Consort Medical Group)、Rewine Pharmaceutical、Abbott Laboratories、Maruishi Pharmaceutical、Collins、Mylan Seiyaku、Baxter、BOC Healthcare、Hikma、Indofine Chemical Company、Medicon Lifesciences、Shandong Keyuan Pharmaceutical、Lunan Pharmaceutical Group、Jiangsu Hengrui Medicineなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

吸入麻酔薬市場は、種類と用途によって区分されます。世界の吸入麻酔薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
揮発性麻酔薬、亜酸化窒素、ハロタン、その他

【用途別セグメント】
病院、クリニック、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 吸入麻酔薬製品概要
- 種類別市場(揮発性麻酔薬、亜酸化窒素、ハロタン、その他)
- 用途別市場(病院、クリニック、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の吸入麻酔薬販売量予測2017-2028
- 世界の吸入麻酔薬売上予測2017-2028
- 吸入麻酔薬の地域別販売量
- 吸入麻酔薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別吸入麻酔薬販売量
- 主要メーカー別吸入麻酔薬売上
- 主要メーカー別吸入麻酔薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(揮発性麻酔薬、亜酸化窒素、ハロタン、その他)
- 吸入麻酔薬の種類別販売量
- 吸入麻酔薬の種類別売上
- 吸入麻酔薬の種類別価格
・用途別市場規模(病院、クリニック、その他)
- 吸入麻酔薬の用途別販売量
- 吸入麻酔薬の用途別売上
- 吸入麻酔薬の用途別価格
・北米市場
- 北米の吸入麻酔薬市場規模(種類別、用途別)
- 主要国別の吸入麻酔薬市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの吸入麻酔薬市場規模(種類別、用途別)
- 主要国別の吸入麻酔薬市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の吸入麻酔薬市場規模(種類別、用途別)
- 主要国別の吸入麻酔薬市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の吸入麻酔薬市場規模(種類別、用途別)
- 主要国別の吸入麻酔薬市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの吸入麻酔薬市場規模(種類別、用途別)
- 主要国別の吸入麻酔薬市場規模(トルコ、サウジアラビア)
・企業情報
Linde Healthcare、Air Products、Taiyo Nippon Sanso、Messer Group、SOL Group、Pfizer、Norco、Piramal Group、Halocarbon、Dideu Group、Innopharmchem、Aesica(Consort Medical Group)、Rewine Pharmaceutical、Abbott Laboratories、Maruishi Pharmaceutical、Collins、Mylan Seiyaku、Baxter、BOC Healthcare、Hikma、Indofine Chemical Company、Medicon Lifesciences、Shandong Keyuan Pharmaceutical、Lunan Pharmaceutical Group、Jiangsu Hengrui Medicine
・産業チェーン及び販売チャネル分析
- 吸入麻酔薬の産業チェーン分析
- 吸入麻酔薬の原材料
- 吸入麻酔薬の生産プロセス
- 吸入麻酔薬の販売及びマーケティング
- 吸入麻酔薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 吸入麻酔薬の産業動向
- 吸入麻酔薬のマーケットドライバー
- 吸入麻酔薬の課題
- 吸入麻酔薬の阻害要因
・主な調査結果

An inhalational anesthetic is a chemical compound possessing general anesthetic properties that can be delivered via inhalation.
Market Analysis and Insights: Global Inhalational Anesthetic Market
Due to the COVID-19 pandemic, the global Inhalational Anesthetic market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Volatile Anesthetic Agents accounting for % of the Inhalational Anesthetic global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Inhalational Anesthetic market size is valued at US$ million in 2021, while the US and Europe Inhalational Anesthetic are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Inhalational Anesthetic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Inhalational Anesthetic include Linde Healthcare, Air Products, Taiyo Nippon Sanso, Messer Group, SOL Group, Pfizer, Norco, Piramal Group and Halocarbon, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Inhalational Anesthetic Scope and Segment
Inhalational Anesthetic market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Inhalational Anesthetic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Volatile Anesthetic Agents
Nitrous Oxide
Halothane
Others
Segment by Application
Hospital
Clinic
Others
By Company
Linde Healthcare
Air Products
Taiyo Nippon Sanso
Messer Group
SOL Group
Pfizer
Norco
Piramal Group
Halocarbon
Dideu Group
Innopharmchem
Aesica(Consort Medical Group)
Rewine Pharmaceutical
Abbott Laboratories
Maruishi Pharmaceutical
Collins
Mylan Seiyaku
Baxter
BOC Healthcare
Hikma
Indofine Chemical Company
Medicon Lifesciences
Shandong Keyuan Pharmaceutical
Lunan Pharmaceutical Group
Jiangsu Hengrui Medicine
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Inhalational Anesthetic Product Introduction
1.2 Market by Type
1.2.1 Global Inhalational Anesthetic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Volatile Anesthetic Agents
1.2.3 Nitrous Oxide
1.2.4 Halothane
1.2.5 Others
1.3 Market by Application
1.3.1 Global Inhalational Anesthetic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Inhalational Anesthetic Sales Estimates and Forecasts 2017-2028
2.2 Global Inhalational Anesthetic Revenue Estimates and Forecasts 2017-2028
2.3 Global Inhalational Anesthetic Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Inhalational Anesthetic Sales by Region
2.4.1 Global Inhalational Anesthetic Sales by Region (2017-2022)
2.4.2 Global Sales Inhalational Anesthetic by Region (2023-2028)
2.5 Global Inhalational Anesthetic Revenue by Region
2.5.1 Global Inhalational Anesthetic Revenue by Region (2017-2022)
2.5.2 Global Inhalational Anesthetic Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Inhalational Anesthetic Sales by Manufacturers
3.1.1 Global Top Inhalational Anesthetic Manufacturers by Sales (2017-2022)
3.1.2 Global Inhalational Anesthetic Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inhalational Anesthetic in 2021
3.2 Global Inhalational Anesthetic Revenue by Manufacturers
3.2.1 Global Inhalational Anesthetic Revenue by Manufacturers (2017-2022)
3.2.2 Global Inhalational Anesthetic Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Inhalational Anesthetic Revenue in 2021
3.3 Global Inhalational Anesthetic Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Inhalational Anesthetic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Inhalational Anesthetic Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inhalational Anesthetic Sales by Type
4.1.1 Global Inhalational Anesthetic Historical Sales by Type (2017-2022)
4.1.2 Global Inhalational Anesthetic Forecasted Sales by Type (2023-2028)
4.1.3 Global Inhalational Anesthetic Sales Market Share by Type (2017-2028)
4.2 Global Inhalational Anesthetic Revenue by Type
4.2.1 Global Inhalational Anesthetic Historical Revenue by Type (2017-2022)
4.2.2 Global Inhalational Anesthetic Forecasted Revenue by Type (2023-2028)
4.2.3 Global Inhalational Anesthetic Revenue Market Share by Type (2017-2028)
4.3 Global Inhalational Anesthetic Price by Type
4.3.1 Global Inhalational Anesthetic Price by Type (2017-2022)
4.3.2 Global Inhalational Anesthetic Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Inhalational Anesthetic Sales by Application
5.1.1 Global Inhalational Anesthetic Historical Sales by Application (2017-2022)
5.1.2 Global Inhalational Anesthetic Forecasted Sales by Application (2023-2028)
5.1.3 Global Inhalational Anesthetic Sales Market Share by Application (2017-2028)
5.2 Global Inhalational Anesthetic Revenue by Application
5.2.1 Global Inhalational Anesthetic Historical Revenue by Application (2017-2022)
5.2.2 Global Inhalational Anesthetic Forecasted Revenue by Application (2023-2028)
5.2.3 Global Inhalational Anesthetic Revenue Market Share by Application (2017-2028)
5.3 Global Inhalational Anesthetic Price by Application
5.3.1 Global Inhalational Anesthetic Price by Application (2017-2022)
5.3.2 Global Inhalational Anesthetic Price Forecast by Application (2023-2028)
6 North America
6.1 North America Inhalational Anesthetic Market Size by Type
6.1.1 North America Inhalational Anesthetic Sales by Type (2017-2028)
6.1.2 North America Inhalational Anesthetic Revenue by Type (2017-2028)
6.2 North America Inhalational Anesthetic Market Size by Application
6.2.1 North America Inhalational Anesthetic Sales by Application (2017-2028)
6.2.2 North America Inhalational Anesthetic Revenue by Application (2017-2028)
6.3 North America Inhalational Anesthetic Market Size by Country
6.3.1 North America Inhalational Anesthetic Sales by Country (2017-2028)
6.3.2 North America Inhalational Anesthetic Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Inhalational Anesthetic Market Size by Type
7.1.1 Europe Inhalational Anesthetic Sales by Type (2017-2028)
7.1.2 Europe Inhalational Anesthetic Revenue by Type (2017-2028)
7.2 Europe Inhalational Anesthetic Market Size by Application
7.2.1 Europe Inhalational Anesthetic Sales by Application (2017-2028)
7.2.2 Europe Inhalational Anesthetic Revenue by Application (2017-2028)
7.3 Europe Inhalational Anesthetic Market Size by Country
7.3.1 Europe Inhalational Anesthetic Sales by Country (2017-2028)
7.3.2 Europe Inhalational Anesthetic Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Inhalational Anesthetic Market Size by Type
8.1.1 Asia Pacific Inhalational Anesthetic Sales by Type (2017-2028)
8.1.2 Asia Pacific Inhalational Anesthetic Revenue by Type (2017-2028)
8.2 Asia Pacific Inhalational Anesthetic Market Size by Application
8.2.1 Asia Pacific Inhalational Anesthetic Sales by Application (2017-2028)
8.2.2 Asia Pacific Inhalational Anesthetic Revenue by Application (2017-2028)
8.3 Asia Pacific Inhalational Anesthetic Market Size by Region
8.3.1 Asia Pacific Inhalational Anesthetic Sales by Region (2017-2028)
8.3.2 Asia Pacific Inhalational Anesthetic Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Inhalational Anesthetic Market Size by Type
9.1.1 Latin America Inhalational Anesthetic Sales by Type (2017-2028)
9.1.2 Latin America Inhalational Anesthetic Revenue by Type (2017-2028)
9.2 Latin America Inhalational Anesthetic Market Size by Application
9.2.1 Latin America Inhalational Anesthetic Sales by Application (2017-2028)
9.2.2 Latin America Inhalational Anesthetic Revenue by Application (2017-2028)
9.3 Latin America Inhalational Anesthetic Market Size by Country
9.3.1 Latin America Inhalational Anesthetic Sales by Country (2017-2028)
9.3.2 Latin America Inhalational Anesthetic Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Inhalational Anesthetic Market Size by Type
10.1.1 Middle East and Africa Inhalational Anesthetic Sales by Type (2017-2028)
10.1.2 Middle East and Africa Inhalational Anesthetic Revenue by Type (2017-2028)
10.2 Middle East and Africa Inhalational Anesthetic Market Size by Application
10.2.1 Middle East and Africa Inhalational Anesthetic Sales by Application (2017-2028)
10.2.2 Middle East and Africa Inhalational Anesthetic Revenue by Application (2017-2028)
10.3 Middle East and Africa Inhalational Anesthetic Market Size by Country
10.3.1 Middle East and Africa Inhalational Anesthetic Sales by Country (2017-2028)
10.3.2 Middle East and Africa Inhalational Anesthetic Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Linde Healthcare
11.1.1 Linde Healthcare Corporation Information
11.1.2 Linde Healthcare Overview
11.1.3 Linde Healthcare Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Linde Healthcare Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Linde Healthcare Recent Developments
11.2 Air Products
11.2.1 Air Products Corporation Information
11.2.2 Air Products Overview
11.2.3 Air Products Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Air Products Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Air Products Recent Developments
11.3 Taiyo Nippon Sanso
11.3.1 Taiyo Nippon Sanso Corporation Information
11.3.2 Taiyo Nippon Sanso Overview
11.3.3 Taiyo Nippon Sanso Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Taiyo Nippon Sanso Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Taiyo Nippon Sanso Recent Developments
11.4 Messer Group
11.4.1 Messer Group Corporation Information
11.4.2 Messer Group Overview
11.4.3 Messer Group Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Messer Group Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Messer Group Recent Developments
11.5 SOL Group
11.5.1 SOL Group Corporation Information
11.5.2 SOL Group Overview
11.5.3 SOL Group Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 SOL Group Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 SOL Group Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Norco
11.7.1 Norco Corporation Information
11.7.2 Norco Overview
11.7.3 Norco Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Norco Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Norco Recent Developments
11.8 Piramal Group
11.8.1 Piramal Group Corporation Information
11.8.2 Piramal Group Overview
11.8.3 Piramal Group Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Piramal Group Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Piramal Group Recent Developments
11.9 Halocarbon
11.9.1 Halocarbon Corporation Information
11.9.2 Halocarbon Overview
11.9.3 Halocarbon Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Halocarbon Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Halocarbon Recent Developments
11.10 Dideu Group
11.10.1 Dideu Group Corporation Information
11.10.2 Dideu Group Overview
11.10.3 Dideu Group Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Dideu Group Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Dideu Group Recent Developments
11.11 Innopharmchem
11.11.1 Innopharmchem Corporation Information
11.11.2 Innopharmchem Overview
11.11.3 Innopharmchem Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Innopharmchem Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Innopharmchem Recent Developments
11.12 Aesica(Consort Medical Group)
11.12.1 Aesica(Consort Medical Group) Corporation Information
11.12.2 Aesica(Consort Medical Group) Overview
11.12.3 Aesica(Consort Medical Group) Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Aesica(Consort Medical Group) Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aesica(Consort Medical Group) Recent Developments
11.13 Rewine Pharmaceutical
11.13.1 Rewine Pharmaceutical Corporation Information
11.13.2 Rewine Pharmaceutical Overview
11.13.3 Rewine Pharmaceutical Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Rewine Pharmaceutical Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Rewine Pharmaceutical Recent Developments
11.14 Abbott Laboratories
11.14.1 Abbott Laboratories Corporation Information
11.14.2 Abbott Laboratories Overview
11.14.3 Abbott Laboratories Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Abbott Laboratories Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Abbott Laboratories Recent Developments
11.15 Maruishi Pharmaceutical
11.15.1 Maruishi Pharmaceutical Corporation Information
11.15.2 Maruishi Pharmaceutical Overview
11.15.3 Maruishi Pharmaceutical Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Maruishi Pharmaceutical Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Maruishi Pharmaceutical Recent Developments
11.16 Collins
11.16.1 Collins Corporation Information
11.16.2 Collins Overview
11.16.3 Collins Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Collins Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Collins Recent Developments
11.17 Mylan Seiyaku
11.17.1 Mylan Seiyaku Corporation Information
11.17.2 Mylan Seiyaku Overview
11.17.3 Mylan Seiyaku Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Mylan Seiyaku Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Mylan Seiyaku Recent Developments
11.18 Baxter
11.18.1 Baxter Corporation Information
11.18.2 Baxter Overview
11.18.3 Baxter Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Baxter Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Baxter Recent Developments
11.19 BOC Healthcare
11.19.1 BOC Healthcare Corporation Information
11.19.2 BOC Healthcare Overview
11.19.3 BOC Healthcare Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 BOC Healthcare Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 BOC Healthcare Recent Developments
11.20 Hikma
11.20.1 Hikma Corporation Information
11.20.2 Hikma Overview
11.20.3 Hikma Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Hikma Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Hikma Recent Developments
11.21 Indofine Chemical Company
11.21.1 Indofine Chemical Company Corporation Information
11.21.2 Indofine Chemical Company Overview
11.21.3 Indofine Chemical Company Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Indofine Chemical Company Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Indofine Chemical Company Recent Developments
11.22 Medicon Lifesciences
11.22.1 Medicon Lifesciences Corporation Information
11.22.2 Medicon Lifesciences Overview
11.22.3 Medicon Lifesciences Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Medicon Lifesciences Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Medicon Lifesciences Recent Developments
11.23 Shandong Keyuan Pharmaceutical
11.23.1 Shandong Keyuan Pharmaceutical Corporation Information
11.23.2 Shandong Keyuan Pharmaceutical Overview
11.23.3 Shandong Keyuan Pharmaceutical Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Shandong Keyuan Pharmaceutical Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Shandong Keyuan Pharmaceutical Recent Developments
11.24 Lunan Pharmaceutical Group
11.24.1 Lunan Pharmaceutical Group Corporation Information
11.24.2 Lunan Pharmaceutical Group Overview
11.24.3 Lunan Pharmaceutical Group Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Lunan Pharmaceutical Group Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Lunan Pharmaceutical Group Recent Developments
11.25 Jiangsu Hengrui Medicine
11.25.1 Jiangsu Hengrui Medicine Corporation Information
11.25.2 Jiangsu Hengrui Medicine Overview
11.25.3 Jiangsu Hengrui Medicine Inhalational Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 Jiangsu Hengrui Medicine Inhalational Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Jiangsu Hengrui Medicine Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inhalational Anesthetic Industry Chain Analysis
12.2 Inhalational Anesthetic Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inhalational Anesthetic Production Mode & Process
12.4 Inhalational Anesthetic Sales and Marketing
12.4.1 Inhalational Anesthetic Sales Channels
12.4.2 Inhalational Anesthetic Distributors
12.5 Inhalational Anesthetic Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Inhalational Anesthetic Industry Trends
13.2 Inhalational Anesthetic Market Drivers
13.3 Inhalational Anesthetic Market Challenges
13.4 Inhalational Anesthetic Market Restraints
14 Key Findings in The Global Inhalational Anesthetic Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の吸入麻酔薬市場インサイト及び予測(揮発性麻酔薬、亜酸化窒素、ハロタン、その他)(Global Inhalational Anesthetic Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。